{
    "2018-07-01": [
        [
            {
                "time": "2018-07-01",
                "original_text": "药明康德又要去H股 为啥高破发率还蜂拥至港 连续下跌",
                "features": {
                    "keywords": [
                        "药明康德",
                        "H股",
                        "破发率",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "登陆A股不足两月 药明康德又谋港股上市",
                "features": {
                    "keywords": [
                        "药明康德",
                        "A股",
                        "港股",
                        "上市"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "医药独角兽再谋港股上市 药明康德拟发行H股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "医药",
                        "独角兽",
                        "H股",
                        "发行"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "药明康德：董事会同意公司发行H股并申请在香港联交所主板挂牌上市",
                "features": {
                    "keywords": [
                        "药明康德",
                        "董事会",
                        "H股",
                        "香港联交所",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "药明康德：董事会同意公司申请在港交所主板挂牌上市",
                "features": {
                    "keywords": [
                        "药明康德",
                        "董事会",
                        "港交所",
                        "上市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}